Completed PHASE4 INTERVENTIONAL 2-arm NCT00543426

Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis

Sponsor: Shanghai University of Traditional Chinese Medicine

Interventions Fuzheng Huayu Tablets sham Fuzheng Huayu Tablets (placebo)

Updated 5 times since 2017 Last updated: Mar 6, 2013 Started: Sep 30, 2007 Primary completion: May 31, 2009 Completion: Jun 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Posthepatitic Cirrhosis and is currently completed. Shanghai University of Traditional Chinese Medicine leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai University of Traditional Chinese Medicine

Data source: Shanghai University of Traditional Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China